Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
New report highlights cancer’s toll on racial and ethnic minorities and other underserved populations.
Readily available clinical parameters can identify those at greatest risk for hepatocellular carcinoma.
October is Liver Cancer Awareness Month.
Many people with fatty liver disease have obesity, diabetes and other metabolic conditions.
Rates of liver complications were similar, but HIV-positive people had more non-liver cancers and non-liver-related deaths.
Researchers reported significant changes in liver, cardiovascular and diabetes markers.
Stivarga also improved survival in those with recurrent HCC after a liver transplant.
Nearly half of patients treated with the combination saw their tumors shrink in an early study.
Targeting a protein called cyclin D1 may be beneficial in cancer treatment in the setting of obesity and Type 2 diabetes.
NAFLD is the leading indicator of mortality among Medicare beneficiaries with hepatocellular carcinoma.
Hepatitis A and B can be prevented with vaccines, and hepatitis C can be cured with antiviral treatment.
The profile of chronic liver disease has changed due to obesity trends and advances in the treatment of hepatitis C.
It was natural for me to remain physically active before and after my liver transplant.
If you have liver disease or any immune compromising condition, you are at risk of becoming sick from virus, flu and other infection.
The immunotherapy and targeted therapy combo improved both overall survival and patient-reported outcomes.
The Supreme Court justice, who is undergoing biweekly chemotherapy, says she remains fully able to carry out her work on the court.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.